NDC 65841-536

Potassium Citrate

Potassium Citrate

Potassium Citrate is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Potassium Citrate.

Product ID65841-536_01c62b42-cd67-4a44-8ac9-7daa079ce528
NDC65841-536
Product TypeHuman Prescription Drug
Proprietary NamePotassium Citrate
Generic NamePotassium Citrate
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2014-08-12
Marketing CategoryANDA / ANDA
Application NumberANDA203546
Labeler NameCadila Healthcare Limited
Substance NamePOTASSIUM CITRATE
Active Ingredient Strength5 meq/1
Pharm ClassesAcidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 65841-536-01

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-536-01)
Marketing Start Date2014-08-12
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65841-536-16 [65841053616]

Potassium Citrate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA203546
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-12

NDC 65841-536-01 [65841053601]

Potassium Citrate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA203546
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-12

NDC 65841-536-05 [65841053605]

Potassium Citrate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA203546
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-12

NDC 65841-536-30 [65841053630]

Potassium Citrate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA203546
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-12

NDC 65841-536-06 [65841053606]

Potassium Citrate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA203546
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-12

NDC 65841-536-10 [65841053610]

Potassium Citrate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA203546
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-08-12

Drug Details

Active Ingredients

IngredientStrength
POTASSIUM CITRATE5 meq/1

OpenFDA Data

SPL SET ID:39f46084-fc4b-4bfc-91cb-9be7e647655a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199381
  • 898490
  • 199376
  • UPC Code
  • 0365841537017
  • 0365841538014
  • 0365841536010
  • Pharmacological Class

    • Acidifying Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Anti-coagulant [EPC]
    • Decreased Coagulation Factor Activity [PE]
    • Calcium Chelating Activity [MoA]

    NDC Crossover Matching brand name "Potassium Citrate" or generic name "Potassium Citrate"

    NDCBrand NameGeneric Name
    0245-0070Potassium Citratepotassium citrate
    0245-0071Potassium Citratepotassium citrate
    68084-850Potassium CitratePotassium Citrate
    68382-538Potassium CitratePotassium Citrate
    68382-536Potassium CitratePotassium Citrate
    68382-537Potassium CitratePotassium Citrate
    0591-2742Potassium CitratePotassium Citrate
    0591-2682Potassium CitratePotassium Citrate
    0591-2729Potassium CitratePotassium Citrate
    44523-415Potassium CitratePotassium Citrate
    65841-536Potassium CitratePotassium Citrate
    65841-537Potassium CitratePotassium Citrate
    65841-538Potassium CitratePotassium Citrate
    63629-7980Potassium CitratePotassium Citrate
    62559-292Potassium CitratePotassium Citrate
    62559-291Potassium CitratePotassium Citrate
    42291-500Potassium CitratePotassium Citrate
    63629-1966Potassium CitratePotassium Citrate
    69452-193Potassium CitratePotassium Citrate
    42291-499Potassium CitratePotassium Citrate
    63629-1967Potassium CitratePotassium Citrate
    69452-194Potassium CitratePotassium Citrate
    0178-0600UROCIT-Kpotassium citrate
    0178-0610UROCIT-Kpotassium citrate
    0178-0615UROCIT-Kpotassium citrate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.